When surgeons perform brain surgery on people with brain tumors or epilepsy, they need to remove the tumor or abnormal tissue while preserving parts of the brain that control language and movement.
What’s new
A new Northwestern Medicine study published in Nature Communications may better inform doctors’ decisions about which brain areas to preserve, thereby improving patients’ language function after brain surgery. The study expands the understanding of how language is encoded in the brain and identifies key features of critical sites in the cerebral cortex that work together to produce language.
Why it matters
If you think of the brain’s language network as a social network, scientists have essentially found the person who is the link between lots of subnetworks of people. They wouldn’t know each other if not for this single person. In the brain, these “connectors” serve the same function for language. If the connector sites were removed, the patient would make more language errors after surgery — such as difficulty naming objects — because the subnetworks couldn’t work together.
The process
Northwestern scientists identified the critical language connector sites by recording electrical signals from the cortex of the brain in patients with epilepsy or brain tumors while the patients read words aloud. Investigators then analyzed the signals using graph theory methods and machine learning to predict which sites in the network were critical.
“This discovery could help us be more precise and efficient when we’re mapping language sites before surgery,” said corresponding author Dr. Marc Slutzky, professor of neurology at Northwestern University Feinberg School of Medicine and a Northwestern Medicine neurologist. “It could help us augment the way surgeons do this mapping, so ultimately it could potentially shorten the time needed for stimulation or possibly eliminate the stimulation and just record electrical signals.”
People with brain tumors or epilepsy who need surgery often undergo functional mapping using direct electrical stimulation of the brain to try to identify critical parts of the brain (particularly in the cerebral cortex) so neurosurgeons know which sites to avoid removing to preserve language. For example, the electrical stimulation might temporarily interrupt the ability to speak or conceive of names for objects, which would suggest that the area to which stimulation was applied is important to speech or to language function.
The current stimulation technique has limits
“The way this is done hasn’t changed significantly in over 50 years, yet exactly what is happening during this stimulation is still not well understood,” Slutzky said. “It is not clear what is special about the focal sites identified by stimulation as critical to language and speech.
“When someone is speaking, many sites in the brain are active, yet only a handful of those sites are identified as critical to those functions by being perturbed during stimulation. Answering this question could help us understand how electrical stimulation affects the brain and how the brain produces spoken language.”
An estimated 1.2 million people in the U.S. are living with brain tumors
Currently, many patients with brain tumors undergo between 20 and 60 minutes of stimulation time while they are awake in surgery. The technique is not perfect for identifying the language sites: results can be false negative or false positive, and the process can cause seizures.
“It’s not fun for the patient,” Slutzky said. “When we do it for epilepsy patients, the mapping can take a day or sometimes two and is exhausting for them.”
Epilepsy patients may need brain surgery when medications don’t adequately control seizures, Slutzky said.
Notes
Other Northwestern study authors are Jason K. Hsieh, Prashanth R. Prakash, Robert D. Flint, Zachary Fitzgerald, Emily Mugler, Jessica W. Templer, Joshua M. Rosenow and Matthew C. Tate.
The Northwestern research was a collaboration between Nathan Crone and Yujing Wang at Johns Hopkins University and Richard Betzel at Indiana University.
The research was funded by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health, the Doris Duke Charitable Foundation, the Northwestern Memorial Foundation Dixon Translational Research Grant and Northwestern Medicine Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Lurie Cancer Center of Northwestern University.